APO Research
Talk to an analyst

APO RESEARCH · REPORT

Compounded Topical Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Compounded Topical Drug Market Analysis and Forecast 2026-2032

29 December 2025207 pages

Choose your research edition.

Industry ResearchCompounded Topical Drug Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Compounded Topical Drug Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Compounded Topical Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Compounded Topical Drug Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Compounded Topical Drug Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Compounded Topical Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Compounded Topical Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Compounded Topical Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Compounded Topical Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Compounded Topical Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Compounded Topical Drug include Triangle Compounding Pharmacy, QuVa Pharma, PharMEDium Services, Pharmaca Integrative Pharmacy, Perrigo Company plc, PCCA (Professional Compounding Centers of America), Nephron Pharmaceuticals Corporation, Medisca and Lorraine’s Pharmacy, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Compounded Topical Drug, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Compounded Topical Drug, also provides the revenue of main regions and countries. Of the upcoming market potential for Compounded Topical Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Compounded Topical Drug revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Compounded Topical Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Compounded Topical Drug revenue, projected growth trends, production technology, application and end-user industry.

Compounded Topical Drug Segment by Company

Triangle Compounding Pharmacy

QuVa Pharma

PharMEDium Services

Pharmaca Integrative Pharmacy

Perrigo Company plc

PCCA (Professional Compounding Centers of America)

Nephron Pharmaceuticals Corporation

Medisca

Lorraine’s Pharmacy

Institutional Pharmacy Solutions

Fresenius Kabi

Fagron

Custom Scripts Pharmacy

Central Admixture Pharmacy Services (CAPS)

CareFirst Specialty Pharmacy

Cantrell Drug Company

B. Braun Melsungen AG Company

Avella Specialty Pharmacy

Atlas Pharmaceuticals

Compounded Topical Drug Segment by Type

Ointments

Lotions

Cream

Gels

Compounded Topical Drug Segment by Application

Hospitals

Retail Pharmacy

Other

Compounded Topical Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Compounded Topical Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Compounded Topical Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Compounded Topical Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Compounded Topical Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Compounded Topical Drug company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Compounded Topical Drug revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Compounded Topical Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Ointments Major Player Table 3. Lotions Major Player Table 4. Cream Major Player Table 5. Gels Major Player Table 6. Global Compounded Topical Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospitals Major Player Table 8. Retail Pharmacy Major Player Table 9. Other Major Player Table 10. Compounded Topical Drug Industry Trends Table 11. Compounded Topical Drug Industry Drivers Table 12. Compounded Topical Drug Industry Opportunities and Challenges Table 13. Compounded Topical Drug Industry Restraints Table 14. Global Compounded Topical Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Compounded Topical Drug Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Compounded Topical Drug Market Share by Region (2021-2026) Table 17. Global Compounded Topical Drug Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Compounded Topical Drug Market Share by Region (2027-2032) Table 19. Global Compounded Topical Drug Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Compounded Topical Drug Revenue Market Share by Players (2021-2026) Table 21. Global Compounded Topical Drug Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Compounded Topical Drug Key Players Headquarters & Area Served Table 23. Global Compounded Topical Drug Players, Product Type & Application Table 24. Global Compounded Topical Drug Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Compounded Topical Drug by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Compounded Topical Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Compounded Topical Drug Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Compounded Topical Drug Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Compounded Topical Drug Revenue Market Share by Type (2021-2026) Table 31. Global Compounded Topical Drug Revenue Market Share by Type (2027-2032) Table 32. Global Compounded Topical Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Compounded Topical Drug Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Compounded Topical Drug Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Compounded Topical Drug Revenue Market Share by Application (2021-2026) Table 36. Global Compounded Topical Drug Revenue Market Share by Application (2027-2032) Table 37. Triangle Compounding Pharmacy Company Information Table 38. Triangle Compounding Pharmacy Business Overview Table 39. Triangle Compounding Pharmacy Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Triangle Compounding Pharmacy Compounded Topical Drug Product Portfolio Table 41. Triangle Compounding Pharmacy Recent Development Table 42. QuVa Pharma Company Information Table 43. QuVa Pharma Business Overview Table 44. QuVa Pharma Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. QuVa Pharma Compounded Topical Drug Product Portfolio Table 46. QuVa Pharma Recent Development Table 47. PharMEDium Services Company Information Table 48. PharMEDium Services Business Overview Table 49. PharMEDium Services Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. PharMEDium Services Compounded Topical Drug Product Portfolio Table 51. PharMEDium Services Recent Development Table 52. Pharmaca Integrative Pharmacy Company Information Table 53. Pharmaca Integrative Pharmacy Business Overview Table 54. Pharmaca Integrative Pharmacy Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Pharmaca Integrative Pharmacy Compounded Topical Drug Product Portfolio Table 56. Pharmaca Integrative Pharmacy Recent Development Table 57. Perrigo Company plc Company Information Table 58. Perrigo Company plc Business Overview Table 59. Perrigo Company plc Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Perrigo Company plc Compounded Topical Drug Product Portfolio Table 61. Perrigo Company plc Recent Development Table 62. PCCA (Professional Compounding Centers of America) Company Information Table 63. PCCA (Professional Compounding Centers of America) Business Overview Table 64. PCCA (Professional Compounding Centers of America) Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. PCCA (Professional Compounding Centers of America) Compounded Topical Drug Product Portfolio Table 66. PCCA (Professional Compounding Centers of America) Recent Development Table 67. Nephron Pharmaceuticals Corporation Company Information Table 68. Nephron Pharmaceuticals Corporation Business Overview Table 69. Nephron Pharmaceuticals Corporation Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Nephron Pharmaceuticals Corporation Compounded Topical Drug Product Portfolio Table 71. Nephron Pharmaceuticals Corporation Recent Development Table 72. Medisca Company Information Table 73. Medisca Business Overview Table 74. Medisca Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Medisca Compounded Topical Drug Product Portfolio Table 76. Medisca Recent Development Table 77. Lorraine’s Pharmacy Company Information Table 78. Lorraine’s Pharmacy Business Overview Table 79. Lorraine’s Pharmacy Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Lorraine’s Pharmacy Compounded Topical Drug Product Portfolio Table 81. Lorraine’s Pharmacy Recent Development Table 82. Institutional Pharmacy Solutions Company Information Table 83. Institutional Pharmacy Solutions Business Overview Table 84. Institutional Pharmacy Solutions Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Institutional Pharmacy Solutions Compounded Topical Drug Product Portfolio Table 86. Institutional Pharmacy Solutions Recent Development Table 87. Fresenius Kabi Company Information Table 88. Fresenius Kabi Business Overview Table 89. Fresenius Kabi Compounded Topical Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Fresenius Kabi Compounded Topical Drug Product Portfolio Table 91. Fresenius Kabi Recent Development Table 92. Fagron Company Information Table 93. Fagron Business Overview Table 94. Fagron Compounded Topical Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Fagron Compounded Topical Drug Product Portfolio Table 96. Fagron Recent Development Table 97. Custom Scripts Pharmacy Company Information Table 98. Custom Scripts Pharmacy Business Overview Table 99. Custom Scripts Pharmacy Compounded Topical Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Custom Scripts Pharmacy Compounded Topical Drug Product Portfolio Table 101. Custom Scripts Pharmacy Recent Development Table 102. Central Admixture Pharmacy Services (CAPS) Company Information Table 103. Central Admixture Pharmacy Services (CAPS) Business Overview Table 104. Central Admixture Pharmacy Services (CAPS) Compounded Topical Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Central Admixture Pharmacy Services (CAPS) Compounded Topical Drug Product Portfolio Table 106. Central Admixture Pharmacy Services (CAPS) Recent Development Table 107. CareFirst Specialty Pharmacy Company Information Table 108. CareFirst Specialty Pharmacy Business Overview Table 109. CareFirst Specialty Pharmacy Compounded Topical Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. CareFirst Specialty Pharmacy Compounded Topical Drug Product Portfolio Table 111. CareFirst Specialty Pharmacy Recent Development Table 112. Cantrell Drug Company Company Information Table 113. Cantrell Drug Company Business Overview Table 114. Cantrell Drug Company Compounded Topical Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Cantrell Drug Company Compounded Topical Drug Product Portfolio Table 116. Cantrell Drug Company Recent Development Table 117. B. Braun Melsungen AG Company Company Information Table 118. B. Braun Melsungen AG Company Business Overview Table 119. B. Braun Melsungen AG Company Compounded Topical Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. B. Braun Melsungen AG Company Compounded Topical Drug Product Portfolio Table 121. B. Braun Melsungen AG Company Recent Development Table 122. Avella Specialty Pharmacy Company Information Table 123. Avella Specialty Pharmacy Business Overview Table 124. Avella Specialty Pharmacy Compounded Topical Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Avella Specialty Pharmacy Compounded Topical Drug Product Portfolio Table 126. Avella Specialty Pharmacy Recent Development Table 127. Atlas Pharmaceuticals Company Information Table 128. Atlas Pharmaceuticals Business Overview Table 129. Atlas Pharmaceuticals Compounded Topical Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Atlas Pharmaceuticals Compounded Topical Drug Product Portfolio Table 131. Atlas Pharmaceuticals Recent Development Table 132. North America Compounded Topical Drug Revenue by Type (2021-2026) & (US$ Million) Table 133. North America Compounded Topical Drug Revenue by Type (2027-2032) & (US$ Million) Table 134. North America Compounded Topical Drug Revenue by Application (2021-2026) & (US$ Million) Table 135. North America Compounded Topical Drug Revenue by Application (2027-2032) & (US$ Million) Table 136. North America Compounded Topical Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. North America Compounded Topical Drug Revenue by Country (2021-2026) & (US$ Million) Table 138. North America Compounded Topical Drug Revenue by Country (US$ Million) & (2027-2032) Table 139. Europe Compounded Topical Drug Revenue by Type (2021-2026) & (US$ Million) Table 140. Europe Compounded Topical Drug Revenue by Type (2027-2032) & (US$ Million) Table 141. Europe Compounded Topical Drug Revenue by Application (2021-2026) & (US$ Million) Table 142. Europe Compounded Topical Drug Revenue by Application (2027-2032) & (US$ Million) Table 143. Europe Compounded Topical Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. Europe Compounded Topical Drug Revenue by Country (2021-2026) & (US$ Million) Table 145. Europe Compounded Topical Drug Revenue by Country (US$ Million) & (2027-2032) Table 146. China Compounded Topical Drug Revenue by Type (2021-2026) & (US$ Million) Table 147. China Compounded Topical Drug Revenue by Type (2027-2032) & (US$ Million) Table 148. China Compounded Topical Drug Revenue by Application (2021-2026) & (US$ Million) Table 149. China Compounded Topical Drug Revenue by Application (2027-2032) & (US$ Million) Table 150. Asia Compounded Topical Drug Revenue by Type (2021-2026) & (US$ Million) Table 151. Asia Compounded Topical Drug Revenue by Type (2027-2032) & (US$ Million) Table 152. Asia Compounded Topical Drug Revenue by Application (2021-2026) & (US$ Million) Table 153. Asia Compounded Topical Drug Revenue by Application (2027-2032) & (US$ Million) Table 154. Asia Compounded Topical Drug Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 155. Asia Compounded Topical Drug Revenue by Region (US$ Million) & (2021-2026) Table 156. Asia Compounded Topical Drug Revenue by Region (US$ Million) & (2027-2032) Table 157. SAMEA Compounded Topical Drug Revenue by Type (2021-2026) & (US$ Million) Table 158. SAMEA Compounded Topical Drug Revenue by Type (2027-2032) & (US$ Million) Table 159. SAMEA Compounded Topical Drug Revenue by Application (2021-2026) & (US$ Million) Table 160. SAMEA Compounded Topical Drug Revenue by Application (2027-2032) & (US$ Million) Table 161. SAMEA Compounded Topical Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 162. SAMEA Compounded Topical Drug Revenue by Country (2021-2026) & (US$ Million) Table 163. SAMEA Compounded Topical Drug Revenue by Country (US$ Million) & (2027-2032) Table 164. Research Programs/Design for This Report Table 165. Authors List of This Report Table 166. Secondary Sources Table 167. Primary Sources List of Figures Figure 1. Compounded Topical Drug Image Figure 2. Global Compounded Topical Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Compounded Topical Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Ointments Image Figure 5. Lotions Image Figure 6. Cream Image Figure 7. Gels Image Figure 8. Global Compounded Topical Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Compounded Topical Drug Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospitals Image Figure 11. Retail Pharmacy Image Figure 12. Other Image Figure 13. Global Compounded Topical Drug Market Size (US$ Million) & (2021-2032) Figure 14. Global Compounded Topical Drug Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Compounded Topical Drug Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Compounded Topical Drug Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Compounded Topical Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Compounded Topical Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Compounded Topical Drug Revenue Market Share by Type (2021-2032) Figure 21. Global Compounded Topical Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Compounded Topical Drug Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Compounded Topical Drug Revenue Market Share by Application (2021-2032) Figure 24. North America Compounded Topical Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Compounded Topical Drug Revenue Share by Type (2021-2032) Figure 26. North America Compounded Topical Drug Revenue Share by Application (2021-2032) Figure 27. North America Compounded Topical Drug Revenue Share by Country (2021-2032) Figure 28. United States Compounded Topical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Compounded Topical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Compounded Topical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Compounded Topical Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Compounded Topical Drug Revenue Share by Type (2021-2032) Figure 33. Europe Compounded Topical Drug Revenue Share by Application (2021-2032) Figure 34. Europe Compounded Topical Drug Revenue Share by Country (2021-2032) Figure 35. Germany Compounded Topical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Compounded Topical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Compounded Topical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Compounded Topical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Compounded Topical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Compounded Topical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Compounded Topical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Compounded Topical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Compounded Topical Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Compounded Topical Drug Revenue Share by Type (2021-2032) Figure 45. China Compounded Topical Drug Revenue Share by Application (2021-2032) Figure 46. Asia Compounded Topical Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Compounded Topical Drug Revenue Share by Type (2021-2032) Figure 48. Asia Compounded Topical Drug Revenue Share by Application (2021-2032) Figure 49. Asia Compounded Topical Drug Revenue Share by Region (2021-2032) Figure 50. Japan Compounded Topical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Compounded Topical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Compounded Topical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Compounded Topical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Compounded Topical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Compounded Topical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Compounded Topical Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Compounded Topical Drug Revenue Share by Type (2021-2032) Figure 58. SAMEA Compounded Topical Drug Revenue Share by Application (2021-2032) Figure 59. SAMEA Compounded Topical Drug Revenue Share by Country (2021-2032) Figure 60. Brazil Compounded Topical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Compounded Topical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Compounded Topical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Compounded Topical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Compounded Topical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Compounded Topical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Compounded Topical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Compounded Topical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Compounded Topical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Compounded Topical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Compounded Topical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Ointments
  • Lotions
  • Cream
  • Gels
Applications
  • Hospitals
  • Retail Pharmacy
  • Other
Companies covered
  • Triangle Compounding Pharmacy
  • QuVa Pharma
  • PharMEDium Services
  • Pharmaca Integrative Pharmacy
  • Perrigo Company plc
  • PCCA (Professional Compounding Centers of America)
  • Nephron Pharmaceuticals Corporation
  • Medisca
  • Lorraine’s Pharmacy
  • Institutional Pharmacy Solutions
  • Fresenius Kabi
  • Fagron
  • Custom Scripts Pharmacy
  • Central Admixture Pharmacy Services (CAPS)
  • CareFirst Specialty Pharmacy
  • Cantrell Drug Company
  • B. Braun Melsungen AG Company
  • Avella Specialty Pharmacy
  • Atlas Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Compounded Topical Drug Market by Type
  3. 1.2.1 Global Compounded Topical Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Ointments
  5. 1.2.3 Lotions
  6. 1.2.4 Cream
  7. 1.2.5 Gels
  8. 1.3 Compounded Topical Drug Market by Application
  9. 1.3.1 Global Compounded Topical Drug Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospitals
  11. 1.3.3 Retail Pharmacy
  12. 1.3.4 Other
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Compounded Topical Drug Market Dynamics
  1. 2.1 Compounded Topical Drug Industry Trends
  2. 2.2 Compounded Topical Drug Industry Drivers
  3. 2.3 Compounded Topical Drug Industry Opportunities and Challenges
  4. 2.4 Compounded Topical Drug Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Compounded Topical Drug Market Perspective (2021-2032)
  2. 3.2 Global Compounded Topical Drug Growth Trends by Region
  3. 3.2.1 Global Compounded Topical Drug Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Compounded Topical Drug Market Size by Region (2021-2026)
  5. 3.2.3 Global Compounded Topical Drug Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Compounded Topical Drug Revenue by Players
  2. 4.1.1 Global Compounded Topical Drug Revenue by Players (2021-2026)
  3. 4.1.2 Global Compounded Topical Drug Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Compounded Topical Drug Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Compounded Topical Drug Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Compounded Topical Drug Key Players Headquarters & Area Served
  7. 4.4 Global Compounded Topical Drug Players, Product Type & Application
  8. 4.5 Global Compounded Topical Drug Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Compounded Topical Drug Market CR5 and HHI
  11. 4.6.3 2025 Compounded Topical Drug Tier 1, Tier 2, and Tier 3
5 Compounded Topical Drug Market Size by Type
  1. 5.1 Global Compounded Topical Drug Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Compounded Topical Drug Revenue by Type (2021-2032)
  3. 5.3 Global Compounded Topical Drug Revenue Market Share by Type (2021-2032)
6 Compounded Topical Drug Market Size by Application
  1. 6.1 Global Compounded Topical Drug Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Compounded Topical Drug Revenue by Application (2021-2032)
  3. 6.3 Global Compounded Topical Drug Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Triangle Compounding Pharmacy
  2. 7.1.1 Triangle Compounding Pharmacy Company Information
  3. 7.1.2 Triangle Compounding Pharmacy Business Overview
  4. 7.1.3 Triangle Compounding Pharmacy Compounded Topical Drug Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Triangle Compounding Pharmacy Compounded Topical Drug Product Portfolio
  6. 7.1.5 Triangle Compounding Pharmacy Recent Developments
  7. 7.2 QuVa Pharma
  8. 7.2.1 QuVa Pharma Company Information
  9. 7.2.2 QuVa Pharma Business Overview
  10. 7.2.3 QuVa Pharma Compounded Topical Drug Revenue and Gross Margin (2021-2026)
  11. 7.2.4 QuVa Pharma Compounded Topical Drug Product Portfolio
  12. 7.2.5 QuVa Pharma Recent Developments
  13. 7.3 PharMEDium Services
  14. 7.3.1 PharMEDium Services Company Information
  15. 7.3.2 PharMEDium Services Business Overview
  16. 7.3.3 PharMEDium Services Compounded Topical Drug Revenue and Gross Margin (2021-2026)
  17. 7.3.4 PharMEDium Services Compounded Topical Drug Product Portfolio
  18. 7.3.5 PharMEDium Services Recent Developments
  19. 7.4 Pharmaca Integrative Pharmacy
  20. 7.4.1 Pharmaca Integrative Pharmacy Company Information
  21. 7.4.2 Pharmaca Integrative Pharmacy Business Overview
  22. 7.4.3 Pharmaca Integrative Pharmacy Compounded Topical Drug Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Pharmaca Integrative Pharmacy Compounded Topical Drug Product Portfolio
  24. 7.4.5 Pharmaca Integrative Pharmacy Recent Developments
  25. 7.5 Perrigo Company plc
  26. 7.5.1 Perrigo Company plc Company Information
  27. 7.5.2 Perrigo Company plc Business Overview
  28. 7.5.3 Perrigo Company plc Compounded Topical Drug Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Perrigo Company plc Compounded Topical Drug Product Portfolio
  30. 7.5.5 Perrigo Company plc Recent Developments
  31. 7.6 PCCA (Professional Compounding Centers of America)
  32. 7.6.1 PCCA (Professional Compounding Centers of America) Company Information
  33. 7.6.2 PCCA (Professional Compounding Centers of America) Business Overview
  34. 7.6.3 PCCA (Professional Compounding Centers of America) Compounded Topical Drug Revenue and Gross Margin (2021-2026)
  35. 7.6.4 PCCA (Professional Compounding Centers of America) Compounded Topical Drug Product Portfolio
  36. 7.6.5 PCCA (Professional Compounding Centers of America) Recent Developments
  37. 7.7 Nephron Pharmaceuticals Corporation
  38. 7.7.1 Nephron Pharmaceuticals Corporation Company Information
  39. 7.7.2 Nephron Pharmaceuticals Corporation Business Overview
  40. 7.7.3 Nephron Pharmaceuticals Corporation Compounded Topical Drug Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Nephron Pharmaceuticals Corporation Compounded Topical Drug Product Portfolio
  42. 7.7.5 Nephron Pharmaceuticals Corporation Recent Developments
  43. 7.8 Medisca
  44. 7.8.1 Medisca Company Information
  45. 7.8.2 Medisca Business Overview
  46. 7.8.3 Medisca Compounded Topical Drug Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Medisca Compounded Topical Drug Product Portfolio
  48. 7.8.5 Medisca Recent Developments
  49. 7.9 Lorraine’s Pharmacy
  50. 7.9.1 Lorraine’s Pharmacy Company Information
  51. 7.9.2 Lorraine’s Pharmacy Business Overview
  52. 7.9.3 Lorraine’s Pharmacy Compounded Topical Drug Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Lorraine’s Pharmacy Compounded Topical Drug Product Portfolio
  54. 7.9.5 Lorraine’s Pharmacy Recent Developments
  55. 7.10 Institutional Pharmacy Solutions
  56. 7.10.1 Institutional Pharmacy Solutions Company Information
  57. 7.10.2 Institutional Pharmacy Solutions Business Overview
  58. 7.10.3 Institutional Pharmacy Solutions Compounded Topical Drug Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Institutional Pharmacy Solutions Compounded Topical Drug Product Portfolio
  60. 7.10.5 Institutional Pharmacy Solutions Recent Developments
  61. 7.11 Fresenius Kabi
  62. 7.11.1 Fresenius Kabi Company Information
  63. 7.11.2 Fresenius Kabi Business Overview
  64. 7.11.3 Fresenius Kabi Compounded Topical Drug Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Fresenius Kabi Compounded Topical Drug Product Portfolio
  66. 7.11.5 Fresenius Kabi Recent Developments
  67. 7.12 Fagron
  68. 7.12.1 Fagron Company Information
  69. 7.12.2 Fagron Business Overview
  70. 7.12.3 Fagron Compounded Topical Drug Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Fagron Compounded Topical Drug Product Portfolio
  72. 7.12.5 Fagron Recent Developments
  73. 7.13 Custom Scripts Pharmacy
  74. 7.13.1 Custom Scripts Pharmacy Company Information
  75. 7.13.2 Custom Scripts Pharmacy Business Overview
  76. 7.13.3 Custom Scripts Pharmacy Compounded Topical Drug Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Custom Scripts Pharmacy Compounded Topical Drug Product Portfolio
  78. 7.13.5 Custom Scripts Pharmacy Recent Developments
  79. 7.14 Central Admixture Pharmacy Services (CAPS)
  80. 7.14.1 Central Admixture Pharmacy Services (CAPS) Company Information
  81. 7.14.2 Central Admixture Pharmacy Services (CAPS) Business Overview
  82. 7.14.3 Central Admixture Pharmacy Services (CAPS) Compounded Topical Drug Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Central Admixture Pharmacy Services (CAPS) Compounded Topical Drug Product Portfolio
  84. 7.14.5 Central Admixture Pharmacy Services (CAPS) Recent Developments
  85. 7.15 CareFirst Specialty Pharmacy
  86. 7.15.1 CareFirst Specialty Pharmacy Company Information
  87. 7.15.2 CareFirst Specialty Pharmacy Business Overview
  88. 7.15.3 CareFirst Specialty Pharmacy Compounded Topical Drug Revenue and Gross Margin (2021-2026)
  89. 7.15.4 CareFirst Specialty Pharmacy Compounded Topical Drug Product Portfolio
  90. 7.15.5 CareFirst Specialty Pharmacy Recent Developments
  91. 7.16 Cantrell Drug Company
  92. 7.16.1 Cantrell Drug Company Company Information
  93. 7.16.2 Cantrell Drug Company Business Overview
  94. 7.16.3 Cantrell Drug Company Compounded Topical Drug Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Cantrell Drug Company Compounded Topical Drug Product Portfolio
  96. 7.16.5 Cantrell Drug Company Recent Developments
  97. 7.17 B. Braun Melsungen AG Company
  98. 7.17.1 B. Braun Melsungen AG Company Company Information
  99. 7.17.2 B. Braun Melsungen AG Company Business Overview
  100. 7.17.3 B. Braun Melsungen AG Company Compounded Topical Drug Revenue and Gross Margin (2021-2026)
  101. 7.17.4 B. Braun Melsungen AG Company Compounded Topical Drug Product Portfolio
  102. 7.17.5 B. Braun Melsungen AG Company Recent Developments
  103. 7.18 Avella Specialty Pharmacy
  104. 7.18.1 Avella Specialty Pharmacy Company Information
  105. 7.18.2 Avella Specialty Pharmacy Business Overview
  106. 7.18.3 Avella Specialty Pharmacy Compounded Topical Drug Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Avella Specialty Pharmacy Compounded Topical Drug Product Portfolio
  108. 7.18.5 Avella Specialty Pharmacy Recent Developments
  109. 7.19 Atlas Pharmaceuticals
  110. 7.19.1 Atlas Pharmaceuticals Company Information
  111. 7.19.2 Atlas Pharmaceuticals Business Overview
  112. 7.19.3 Atlas Pharmaceuticals Compounded Topical Drug Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Atlas Pharmaceuticals Compounded Topical Drug Product Portfolio
  114. 7.19.5 Atlas Pharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Compounded Topical Drug Revenue (2021-2032)
  2. 8.2 North America Compounded Topical Drug Revenue by Type (2021-2032)
  3. 8.2.1 North America Compounded Topical Drug Revenue by Type (2021-2026)
  4. 8.2.2 North America Compounded Topical Drug Revenue by Type (2027-2032)
  5. 8.3 North America Compounded Topical Drug Revenue Share by Type (2021-2032)
  6. 8.4 North America Compounded Topical Drug Revenue by Application (2021-2032)
  7. 8.4.1 North America Compounded Topical Drug Revenue by Application (2021-2026)
  8. 8.4.2 North America Compounded Topical Drug Revenue by Application (2027-2032)
  9. 8.5 North America Compounded Topical Drug Revenue Share by Application (2021-2032)
  10. 8.6 North America Compounded Topical Drug Revenue by Country
  11. 8.6.1 North America Compounded Topical Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Compounded Topical Drug Revenue by Country (2021-2026)
  13. 8.6.3 North America Compounded Topical Drug Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Compounded Topical Drug Revenue (2021-2032)
  2. 9.2 Europe Compounded Topical Drug Revenue by Type (2021-2032)
  3. 9.2.1 Europe Compounded Topical Drug Revenue by Type (2021-2026)
  4. 9.2.2 Europe Compounded Topical Drug Revenue by Type (2027-2032)
  5. 9.3 Europe Compounded Topical Drug Revenue Share by Type (2021-2032)
  6. 9.4 Europe Compounded Topical Drug Revenue by Application (2021-2032)
  7. 9.4.1 Europe Compounded Topical Drug Revenue by Application (2021-2026)
  8. 9.4.2 Europe Compounded Topical Drug Revenue by Application (2027-2032)
  9. 9.5 Europe Compounded Topical Drug Revenue Share by Application (2021-2032)
  10. 9.6 Europe Compounded Topical Drug Revenue by Country
  11. 9.6.1 Europe Compounded Topical Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Compounded Topical Drug Revenue by Country (2021-2026)
  13. 9.6.3 Europe Compounded Topical Drug Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Compounded Topical Drug Revenue (2021-2032)
  2. 10.2 China Compounded Topical Drug Revenue by Type (2021-2032)
  3. 10.2.1 China Compounded Topical Drug Revenue by Type (2021-2026)
  4. 10.2.2 China Compounded Topical Drug Revenue by Type (2027-2032)
  5. 10.3 China Compounded Topical Drug Revenue Share by Type (2021-2032)
  6. 10.4 China Compounded Topical Drug Revenue by Application (2021-2032)
  7. 10.4.1 China Compounded Topical Drug Revenue by Application (2021-2026)
  8. 10.4.2 China Compounded Topical Drug Revenue by Application (2027-2032)
  9. 10.5 China Compounded Topical Drug Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Compounded Topical Drug Revenue (2021-2032)
  2. 11.2 Asia Compounded Topical Drug Revenue by Type (2021-2032)
  3. 11.2.1 Asia Compounded Topical Drug Revenue by Type (2021-2026)
  4. 11.2.2 Asia Compounded Topical Drug Revenue by Type (2027-2032)
  5. 11.3 Asia Compounded Topical Drug Revenue Share by Type (2021-2032)
  6. 11.4 Asia Compounded Topical Drug Revenue by Application (2021-2032)
  7. 11.4.1 Asia Compounded Topical Drug Revenue by Application (2021-2026)
  8. 11.4.2 Asia Compounded Topical Drug Revenue by Application (2027-2032)
  9. 11.5 Asia Compounded Topical Drug Revenue Share by Application (2021-2032)
  10. 11.6 Asia Compounded Topical Drug Revenue by Country
  11. 11.6.1 Asia Compounded Topical Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Compounded Topical Drug Revenue by Country (2021-2026)
  13. 11.6.3 Asia Compounded Topical Drug Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Compounded Topical Drug Revenue (2021-2032)
  2. 12.2 SAMEA Compounded Topical Drug Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Compounded Topical Drug Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Compounded Topical Drug Revenue by Type (2027-2032)
  5. 12.3 SAMEA Compounded Topical Drug Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Compounded Topical Drug Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Compounded Topical Drug Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Compounded Topical Drug Revenue by Application (2027-2032)
  9. 12.5 SAMEA Compounded Topical Drug Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Compounded Topical Drug Revenue by Country
  11. 12.6.1 SAMEA Compounded Topical Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Compounded Topical Drug Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Compounded Topical Drug Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst